John T. Henderson, Director at CYTOKINETICS INC (CYTK), sold 8,750 shares at $63.90 ($559K) on 2025-12-02, disclosed to the SEC on 2025-12-02.
Scheduled sale ($559k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |
| CYTK | SELL | 2024-02-14 | $382K | — | Filing → |